HELIOS-A: 9-month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

被引：0

作者：

Adams, David ^{[1
]}

Tournev, Ivailo L. ^{[2
,3
]}

Taylor, Mark S. ^{[4
,5
]}

Coelho, Teresa ^{[6
]}

Plante-Bordeneuve, Violaine ^{[7
]}

Berk, John L. ^{[8
]}

Gonzalez-Duarte, Alejandra ^{[9
]}

Gillmore, Julian D. ^{[10
]}

Low, Soon-Chai ^{[11
]}

Sekijima, Yoshiki ^{[12
]}

Obici, Laura ^{[13
]}

Blakesley, Rick ^{[14
]}

Arum, Seth ^{[14
]}

Shilling, Rebecca ^{[14
]}

Vest, John ^{[14
]}

Polydefkis, Michael ^{[15
]}

机构：

[1] Univ Paris Saclay, CHU Bicetre, APHP, Dept Neurol,INSERM U1195, Paris, France

[2] Med Univ Sofia, Univ Hosp Aleksandrovska, Dept Neurol, Clin Nervous Dis, Sofia, Bulgaria

[3] New Bulgarian Univ, Dept Cognit Sci, Sofia, Bulgaria

[4] Univ Sydney, Westmead Hosp, Dept Clin Immunol & Allergy, Sydney, NSW, Australia

[5] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia

[6] Hosp Santo Antonio, Ctr Hosp Porto, Porto, Portugal

[7] CHU Henri Mondor, Assistance Publ Hop Paris, Neurol Amyloid network, Creteil, France

[8] Boston Med Ctr, Boston, MA USA

[9] Inst Nacl Ciencias Medicas Nutr Salvador Zubiran, Madrid, Spain

[10] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[11] Univ Malaya, Dept Med, Div Neurol, Kuala Lumpur, Malaysia

[12] Shinshu Univ, Dept Med Neurol Rheumatol, Sch Med, Matsumoto, Nagano, Japan

[13] IRCCS Fdn Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy

[14] Alnylam Pharm, Cambridge, England

[15] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1234

引用

页数：4

共 50 条

[31] Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy
Merkel, Madeline
Grogan, Martha
Hawkins, Philip N.
Kristen, Arnt V.
Berk, John L.
Suhr, Ole B.
Lin, Hollis
McManus, Anastasia
Powell, Christine
Vest, John
Karsten, Verena
Judge, Daniel P.
NEUROLOGY, 2020, 94 (15)
[32] Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
Gillmore, J.
Berk, J.
Dispenzieri, A.
Polydefkis, M.
Gonzalez-Duarte, A.
Sekijima, Y.
Sweetser, M. T.
Arum, S.
Wang, J. J.
White, M. T.
Maurer, M.
EUROPEAN HEART JOURNAL, 2020, 41 : 2129 - 2129
[33] Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
Labeyrie, Celine
Merkel, Madeline
Sethi, Sakshi
Popadic, Lyuba
Yang, Hongbo
Sweetser, Marianne T.
Lin, Hollis
Adams, David
EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
[34] Hereditary transthyretin-mediated amyloidosis with polyneuropathy: baseline anthropometric, demographic and disease characteristics of patients from a reference center
Cunha Sequeira, Vanessa Cristina
Penetra, Maria Alice
Duarte, Lisa
de Azevedo, Fernanda Reis
Santa Rosa Sayegh, Raphael
Pedrosa, Roberto Coury
Cruz, Marcia Waddington
ARQUIVOS DE NEURO-PSIQUIATRIA, 2022, 80 (03) : 262 - 269
[35] Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform
Conceicao, Isabel
Berk, John L.
Weiler, Markus
Kowacs, Pedro A.
Dasgupta, Noel R.
Khella, Sami
Chao, Chi-Chao
Attarian, Shahram
Kwoh, T. Jesse
Jung, Shiangtung W.
Chen, Jersey
Viney, Nicholas J.
Yu, Rosie Z.
Gertz, Morie
Masri, Ahmad
Cruz, Marcia Waddington
Coelho, Teresa
JOURNAL OF NEUROLOGY, 2024, 271 (10) : 6655 - 6666
[36] Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study
Adams, David
Gonzalez-Duarte, Alejandra
O'Riordan, William
Yang, Chih-Chao
Yamashita, Taro
Kristen, Arnt
Tournev, Ivaylo
Schmidt, Hartmut
Coelho, Teresa
Berk, John L.
Lin, Kong-Ping
Dyck, Peter J.
Gandhi, Pritesh
Sweetser, Marianne
Chen, Jihong
Goyal, Sunita
Gollob, Jared
Suhr, Ole
NEUROLOGY, 2018, 90
[37] Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P. Judge
Arnt V. Kristen
Martha Grogan
Mathew S. Maurer
Rodney H. Falk
Mazen Hanna
Julian Gillmore
Pushkal Garg
Akshay K. Vaishnaw
Jamie Harrop
Christine Powell
Verena Karsten
Xiaoping Zhang
Marianne T. Sweetser
John Vest
Philip N. Hawkins
Cardiovascular Drugs and Therapy, 2020, 34 : 889 - 889
[38] LONG-TERM, INTEGRATED CARDIAC SAFETY OF PATISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
Dispenzieri, Angela
Gillmore, Julian
Polydefkis, Michael
Plante-Bordeneuve, Violaine
Schmidt, Hartmut
Berber, Erhan
Wang, Jing Jing
Sweetser, Marianne
White, Matthew
Maurer, Mathew
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 690 - 690
[39] Primary Results From Apollo-B, A Phase 3 Study Of Patisiran In Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy
Maurer, Mathew S.
Fontana, Marianna
Berk, John
Gustafsson, Finn
Simoes, Marcus
Grogan, Martha
Fernandes, Fabio
Gottlieb, Robert L.
Kubanek, Milos
Poulsen, Steen
Damy, Thibaud
Diemberger, Igor
Tahara, Nobuhiro
Yu, Wen-Chung
Tang, W. H. Wilson
Obici, Laura
Gonzalez-Duarte, Alejandra
Sekijima, Yoshiki
White, Matthew T.
Arum, Seth
Jay, Patrick Y.
Vest, John
Gillmore, Julian D.
JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 550 - 550
[40] PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
Longhi, S.
Maurer, M.
Fontana, M.
Berk, J.
Gustafsson, F.
Simoes, M.
Grogan, M.
Fernandes, F.
Gottlieb, R.
Kubanek, M.
Poulsen, S.
Damy, T.
Diemberger, I.
Tahara, N.
Yu, W.
Tang, W.
Obici, L.
Gonzalez-Duarte, A.
Sekijima, Y.
White, M.
Yureneva, E.
Jay, P.
Vest, J.
Gillmore, J.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D28 - D28

← 1 2 3 4 5 →